F20®
Spinal radiopaque bone cement
Product brand names may change depending on the geographical area.

Features
• Medium viscosity
• Low exothermicity <45°C1
• 45% radiopaque agents; Zirconium dioxyde (ZrO2) for X-ray visualisation
(1) Internal reports CLAV051922 and 127/3/TA
Intended use
EU
F20® bone cement is intended for use in palliative percutaneous cementoplasty procedures (such as vertebroplasty or kyphoplasty).
U.S.
The F20® is indicated for the fixation of pathological fractures of the vertebral body using vertebroplasty or kyphoplasty procedures. Painful vertebral compression fractures of the vertebral body may result from osteoporosis, benign lesions (hemangioma), or malignant lesions (metastatic cancers, myeloma).